Leaving methadone treatment: Lessons learned, lessons forgotten, lessons ignored

Mount Sinai Journal of Medicine

Volumn 68, Issue 1, 2001, Pages 62-74

  Magura, Stephan ^a   Rosenblum, Andrew ^a  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

Drug abstinence; Methadone maintenance; Post discharge outcomes

Indexed keywords

METHADONE; OPIATE;

ADDICTION; CONFERENCE PAPER; DRUG DETOXIFICATION; DRUG WITHDRAWAL; HEALTH CARE COST; HOSPITAL DISCHARGE; HUMAN; LITERATURE; LONG TERM CARE; MAINTENANCE THERAPY; MEDICAL ETHICS; METHADONE TREATMENT; MORTALITY; RELAPSE; SOCIAL PSYCHOLOGY; SUBSTITUTION THERAPY;

HUMANS; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT DISCHARGE;

EID: 0035154841     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (74)

1. Lipton DS, Maranda MJ. Detoxification from heroin dependency: An overview of method and effectiveness. Adv Alcohol Subst Abuse 1982; 2(1):31-55.
2. Tennant FS, Rawson RA, Cohen AJ, Mann A. Clinical experience with naltrexone in suburban opioid addicts. J Clin Psychiatry 1984; 45(9 Pt 2):42-45.
3. Mattick RP, Oliphant D, Ward J, Hall W. The effectiveness of other opioid replacement therapies: LAAM, heroin, buprenorphine, naltrexone and injectable maintenance. In: Ward J, Mattick RP, Hall W, editors. Methadone maintenance treatment and other opioid replacement therapies. The Netherlands: Harwood 1998; 6:123-157.
4. Ward J, Mattick RP, Hall W. Methadone maintenance treatment and other opioid replacement therapies. The Netherlands: Harwood; 1998.
5. Payte JT, Khuri ET. Principles of methadone dose determination. In: Parrino M, editor. State methadone treatment guidelines. Treatment Improvement Protocol (TIP) Series. Rockville (MD): Department of Health and Human Services (US); 1993. Report No. 1.
6. Hubbard RL, Marsden ME, Rachal JV, et al. Drug abuse treatment: A national study of effectiveness. Chapel Hill (NC): University of North Carolina Press; 1989.
7. Ball TC, Ross A. The effectiveness of methadone treatment. New York: Springer-Verlag; 1991.
8. Simpson DD, Sells SB. Effectiveness of treatment for drug abuse: An overview of the DARP research program. Adv Alcohol Subst Abuse 1982; 2:7-29.
9. Ward J, Mattick RP, Hall W. The use of methadone during maintenance treatment: Pharmacology, dosage, and treatment outcomes. In: Ward J, Mattick RP, Hall W, editors. Methadone maintenance treatment and other opioid replacement therapies 1998; 9:177-203.
10. Cushman P, Jr. Abstinence following detoxification and methadone maintenance treatment. Am J Med 1978; 65(1):46-52.
11. Senay E. Methadone and public policy. Br J Addict 1988; 83:257-263.
12. Dole VP. Implications of methadone maintenance for theories of narcotic addiction. JAMA 1988; 260(20):3025-3029.
13. Caulkins JP, Satel SL Methadone patients should not be allowed to persist in cocaine use. Drug Policy Analysis Bull 1999; 6:1-6.
14. Magura S, Kang SY, Nwakeze P, Demsky S. Temporal patterns of heroin and cocaine use among methadone patients. Subst Use Misuse 1998; 33(12):2441-2467.
15. Swarns RL. Mayor steps up his criticism of methadone. The New York Times, 1998 Aug 16; Metropolitan Desk.
16. D'Aunno T, Vaughn TE. Variations in methadone treatment practices. JAMA 1992; 267(2):254-258.
17. Rosenbaum M, Murphy SB. Money for methadone. II: Unintended consequences of limited-duration methadone maintenance. J Psychoactive Drugs 1988; 20(4):397-402.
18. Knight KR, Rosenbaum M, Kelley MS, et al. Defunding the poor: The impact of lost access to subsidized methadone maintenance treatment on women injection drug users. J Drug Issues 1996; 26(4):923-942.
19. Gernstein DR, Harwood HJ. Treating drug problems. Vol. 1. Washington (DC): National Academy Press; 1990.
20. Lowinson J, Berle B, Langrod J. Detoxification of long-term methadone patients: Problems and prospects. Int J Addict 1976; 11(6):1009-1018.
21. Joe GW, Simpson DD, Broome KM. Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction 1998; 93(8):1177-1190.
22. Simpson DD, Joe GW, Dansereau DF, Chatham LR. Strategies for improving methadone treatment process and outcomes. J Drug Issues 1997; 27(2):239-260.
23. Milby JB. Methadone maintenance to abstinence. How many make it? J Nerv Ment Dis 1988; 176(7):409-422.
24. Banys P, Tusel DJ, Sees KL, et al. Low (40 mg) versus high (80 mg) dose methadone in a 180-day heroin detoxification program. J Subst Abuse Treat 1994; 11(3):225-232.
25. Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Outcome after methadone treatment: Influence of prior treatment factors and current treatment status. Drug Alcohol Depend 1994; 35(3):223-230.
26. Capelhorn JRM. A comparison of abstinence-oriented and indefinite methadone maintenance treatment. Int J Addict 1994; 29(11):1361-1375.
27. Bell J, Chan J, Kuk A. Investigating the influence of treatment philosophy on outcome of methadone maintenance. Addiction 1995; 90(6):823-830.
28. Kaufman E. The therapeutic community and methadone: A way of achieving abstinence. Int J Addict 1979; 14(1):83-97.
29. Stimmel B, Goldberg J, Rotkopf E, Cohen M. Ability to remain abstinent after methadone detoxification. A six year study. JAMA 1977; 237(12):1216-1220.
30. Sorensen JL, Trier M, Brummett S, et al. Withdrawal from methadone maintenance. Impact of a tapering network support program. J Subst Abuse Treat 1992; 9:21-26.
31. Stimmel B, Goldberg J, Cohen M, Rotkopf E. Detoxification from methadone maintenance: Risk factors associated with relapse to narcotic use. Ann N Y Acad Sci 1978; 311:173-180.
32. Dole VP, Joseph H. Long-term outcome of patient treated with methadone maintenance. Ann N Y Acad Sci 1978; 311:181-189.
33. Zanis DA, McLellan AT, Alterman AI, Cnaan RA. Efficacy of enhanced outreach counseling to reenroll high-risk drug users one year after discharge from treatment. Am J Psychiatry 1996; 153(8):1095-1096.
34. Des Jarlais DC, Joseph H, Dole VP. Long-tern outcomes after termination from methadone maintenance treatment. Ann N Y Acad Sci 1988; 362:231-238.
35. Perkins ME, Bloch HI. A study of some failures in methadone treatment. Am J Psychiatry 1971; 128 (1):47-51.
36. Magura S, Kang SY. Validity of self-reported drug use in high risk populations: A meta-analytical review. Subst Use Misuse 1996; 31(9):1131-1153.
37. Hindin R, McCusker J, Vickers-Lahti M, et al. Radioimmunossay of hair for determination of cocaine, heroin, and marijuana exposure: Comparison with self-report. Int J Addict 1994; 29:771-789.
38. Hoffman JA, Caudill BD, Koman JJ, et al. Psychosocial treatments for cocaine abuse. J Subst Abuse Treat 1996; 13(1):3-11.
39. Lundy A, Gottheil E, McLellan AT, et al. Underreporting of cocaine use at posttreatment follow-up and the measurement of treatment effectiveness. J Nerv Ment Dis 1997; 185:459-462.
40. Magura S, Laudet A, Goldberger B. Improving the validity of behavioral drug abuse research through drug testing. In: Mieczkowski T, editor. Drug testing technology. Assessment of field applications. Boca Raton (FL): CRC Press; 1999.
41. Joseph J, Appel P, Schmeidler J. Deaths during and after discharge from methadone maintenance treatment. Albany (NY): New York State Office of Alcoholism and Substance Abuse Services; 1981 Jun. Outcome Study Report #18.
42. Joseph H, Appel P. Alcoholism and methadone treatment: Consequences for the patient and program. Am J Drug Alcohol Abuse 1985; 11(1&2):37-53.
43. Zanis DA, Woody GE. One-year mortality rates following methadone treatment discharge. Drug Alcohol Depend 1998; 52:257-260.
44. Gearing FR. An epidemiologic evaluation of long-term methadone maintenance treatment for heroin addiction. Am J Epidemiol 1974; 100(2):101-112.
45. Magura S, Kang SY, Rosenblum A, et al. Gender differences in psychiatric comorbidity among cocaine-using opiate addicts. J Addict Dis 1998; 17(3):49-61.
46. Magura S, Nwakeze PC, Demsky S. Pre-and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 1998; 93(1):51-60.
47. Bux DA, Lamb RJ, Iguchi MY. Cocaine use and HIV risk behavior in methadone maintenance patients. Drug Alcohol Depend 1995; 37:29-35.
48. Chaisson RE, Bacchetti P, Osmong E, et al. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989; 261:561-565.
49. Magura S, Rosenblum A, Rodriquez E. Changes in HIV risk behaviors among cocaine-using methadone patients. J Addict Dis 1998; 17(4):71-90.
50. Bourne PG. AIDS and drug use: an international perspective. J Psychoactive Drugs 1988; 20:153-157.
51. Nathan JA, Karan LD. Substance abuse treatment modalities in the age of HIV spectrum disease. J Psychoactive Drugs 1989; 21(4):423-429.
52. Rezza G, Sagliocca L, Zaccarelli M, et al. Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence. Scand J Infect Dis 1996; 28(1):27-29.
53. Kang SY, Magura S, Nwakeze P, Demsky S. Counselor attitudes in methadone maintenance. J Maintenance Addict 1997; 1(2):41-58.
54. Brown BS, Jansen DR, Bass UF. Staff attitudes and conflict regarding the use of methadone in the treatment of heroin addiction. Am J Psychiatry 1974; 131(2):215-218.
55. Capelhorn JRM, Irwig L, Saunders JB. Attitudes and beliefs of staff working in methadone maintenance clinics. Subst Use Misuse 1996; 31(4):437-452.
56. Capelhorn JRM, Hartel DM, Irwig L. Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics. Subst Use Misuse 1997; 32(4):399-413.
57. Eklund C, Hiltunen AJ, Melin L, Borg S. Abstinence fear in methadone maintenance withdrawal: A possible obstacle for getting off methadone. Subst Use Misuse 1977; 32(6):779-792.
58. Goldsmith DS, Hunt DE, Lipton DS, Strug DL. Methadone folklore: Beliefs about side effects and their impact on treatment. Hum Organ 1984; (43):330-340.
59. Rosenblum A, Magura S, Joseph H. Ambivalence toward methadone treatment among intravenous drug users. J Psychoactive Drugs 1991; 23(1):21-27.
60. Kanof PD, Aronson MJ, Ness R. Organic mood syndrome associated with detoxification from methadone maintenance. Am J Psychiatry 1993; 150(3):423-428.
61. Latowsky M. Improving detoxification outcomes from methadone maintenance treatment: The interrelationship of affective states and protracted withdrawal. J Psychoactive Drugs 1996; 28(3):251-257.
62. Salsitz EA, Joseph H, Frank B, et al. Methadone medical maintenance (MMM): Treating chronic opioid dependence in private medical practice - a summary report. Mt Sinai J Med 2000; 67:388-397.
63. Senay E, Barthwell A, Marks R, Bokos PJ. Medical maintenance: An interim report. In: Magura S, Rosenblum A, editors. Experimental therapeutics in addiction medicine. New York: Haworth; 1994. pp. 65-69.
64. Rosenbaum M, Washburn A, Knight K, et al. Treatment as harm reduction, defunding as harm maximization: The case of methadone maintenance. J Psychoactive Drugs 1996; 28(3):241-249.
65. Anglin MD, Speckart GR, Booth MW, Ryan TM. Consequences and costs of shutting off methadone. Addict Behav 1989; 14:307-326.
66. Gossop M, Marsden J, Stewart D, et al. The national treatment outcome research study in the United Kingdom: Six-month follow-up outcomes. Psychology Addict Behav 1997; 11(4):324-337.
67. Gossop M, Green L, Phillips G, Bradley B. Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study. Br J Psychiatry 1989; 154:348-353.
68. Hubbard RL, Craddock SG, Flynn PM, et al. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology Addict Behav 1997; 11(4):261-278.
69. Kosten TR, Rounsaville BJ, Kleber HD. A 2.5 year follow-up of treatment retention and reentry among opioid addicts. J Subst Abuse Treat 1986; 3(3):181-189.
70. Maddux JF, Desmond DP. Outcomes of methadone maintenance one year after admission. J Drug Issues 1997; 27(2):225-238.
71. Maddux JF, McDonald LK. Status of 100 San Antonio addicts one year after admission to methadone maintenance. Drug Forum 1973; 2(3):239-252.
72. McGlothin WH, Anglin MD. Shutting off methadone: Costs and benefits. Arch Gen Psychiatry 1981; 38:1051-1063.
73. Rosenbaum M, Murphy S, Beck J. Money for methadone: Preliminary findings from a study of Alameda County's new maintenance policy. J Psychoactive Drugs 1987; 19(1):13-19.
74. American Society of Addiction Medicine (ASAM). Patient placement criteria for the treatment of substance-related disorders. 2nd edition. Chevy Chase (MD): ASAM; 1996.